GFAP and Alzheimer disease: In accordance with enhanced astrogliosis observed in other AD animal models and post-mortem tissues from AD patients (Verkhratsky et al., 2019), APPKI mice also exhibited significantly greater GFAP expression with a lower molecular weight band at 12 months in RSC compared with age-matched WT mice (p < 0.001, Figure 1A).